Bain Capital gives up majority stake in South Korea Botox Company for $1.5 billion

South Korea's pharmaceutical company Hugel announced its equity Bain Capital to get sold for $1.5 billion.

Related Keywords

China ,Seoul ,Soult Ukpyolsi ,South Korea ,Shanghai ,United States ,Yuanta ,Jiangsu ,Singapore ,America ,Chinese ,South Korean ,Abu Dhabi ,Albert Yong ,Michael Keyoung ,Seo Mi Hwa ,Korea Botox Company Hugel Bain Capital ,Dgs Holdings ,Hong Sihuan Pharmaceutical Holdings ,Deloitte ,Bain Capital ,Seoul Based Hugel ,Korea Botox Company Hugel ,Petra Capital Management ,Managing Director Michael Keyoung ,Hong Kong Listed Sihuan Pharmaceutical Holdings ,Yuanta Securities ,